All In Biotech

Drug Trial Radar · NCT02852564

Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection

Last checked: Nov 20, 2026Latest source record: Aug 22, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12

Actual

Start

Aug 2016

Primary completion

Jul 2017

Study completion Jul 2017

Sponsor

Lead sponsor
Eugene Lee, MDAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Kansas Medical Center
First posted
Aug 2, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 1 study to provide quantitative characterization of the renal elimination of ethacrynic acid and metabolites in patients with non-muscle invasive bladder cancer (NMIBC) at the time of transurethral resection of bladder tumor

Conditions

  • Bladder Cancer

Interventions

  • Ethacrynic AcidDrug

    One oral dose at 50 mg prior to bladder tumor removal surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Urine Concentration - Ethacrynic Acid and its conjugatesTime frame: Baseline at 30 minutes before surgery
  2. Urine Concentration - Ethacrynic Acid and its conjugatesTime frame: During surgery
  3. Urine Concentration - Ethacrynic Acid and its conjugatesTime frame: 2 hours after surgery
  4. Urine Concentration - Ethacrynic Acid and its conjugatesTime frame: 4 hours after surgery
  5. Excretion Rates - Ethacrynic Acid and its conjugatesTime frame: 30 minutes before surgery
  6. Excretion Rates - Ethacrynic Acid and its conjugatesTime frame: during surgery
  7. Excretion Rates - Ethacrynic Acid and its conjugatesTime frame: 2 hours after surgery
  8. Excretion Rates - Ethacrynic Acid and its conjugatesTime frame: 4 hours after surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The University of Kansas Medical Center

    Kansas City, Kansas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.